Medtronic and Boston Scientific Corporation to Account for More Than Half of the Market Share in Terms of Revenue
Cardiac Resynchronization Therapy Device Pacemaker (CRT-P) is expected to register significant growth over the forecast period
Format
PNG
Source
Fortune Business Insights